Malignant Salivary Gland Tumours of the Head and Neck Region: a Single Institutions Review

Overview

Journal Pan Afr Med J

Date 2015 Jul 28

PMID 26213602

Citations 12

Authors

Ahmed Oluwatoyin Lawal

Akinyele Olumuyiwa Adisa

Bamidele Kolude

Bukola Folasade Adeyemi

Affiliations

Soon will be listed here.

Abstract

Introduction: Malignant salivary gland tumours (MSGTs) comprise about 3% of all head and neck cancers; they demonstrate an unpredictable clinical course. The purpose of this study is to review MSGTs seen at a tertiary Health centre, and compare findings with those of previous studies.

Methods: The records of the Department of Oral Pathology and the Department of Pathology, University College Hospital Ibadan were reviewed over a 19 year period and lesions diagnosed as MSGTs according to 2005 WHO histological classification were analysed for age, gender and site using SPSS for Windows (version 20.0; SPSS Inc. Chicago, IL).

Results: MSGTs were more common in males (55.2%) than females (44.8%). The mean age of was 47.9 (±17.0) years and peak age was the fifth decade. The parotid gland was the commonest site with 62 (28.1%) cases. The palate was the commonest intraoral site with 61(27.6%). The nose with 19 (8.6%) was the commonest minor extra-oral site.

Conclusion: The findings were essentially similar to reports from Europe and America. Adenoid Cystic Carcinoma was the most common MSGT in this series. A high proportion of salivary gland tumours in sublingual gland were malignant. The reason(s) for high proportion of MSGTs in sublingual glands requires further investigation.

Citing Articles

A single dose of radiation elicits comparable acute salivary gland injury to fractionated radiation.

Johnson A, Elder S, McKendrick J, Hegarty L, Mercer E, Emmerson E Dis Model Mech. 2024; 17(8).

PMID: 39086326 PMC: 11361643. DOI: 10.1242/dmm.050733.

Epidemiological and histopathological patterns of malignant salivary gland tumors in the Sudanese population.

Mustafa Mohamed Y, Mahmoud H, AbdElrahman Eltahir F, Mohammed Ahmed A, Yousif Y Saudi Dent J. 2024; 36(4):610-614.

PMID: 38690377 PMC: 11056432. DOI: 10.1016/j.sdentj.2024.02.001.

Polymorphous Adenocarcinoma: A Systematic Review of the Literature and Presentation of Two Cases in a Less-Considered Anatomical Site.

Mauceri R, Coppini M, Alecci G, Cordova A, Florena A, Magro G Cancers (Basel). 2024; 16(1).

PMID: 38201647 PMC: 10778460. DOI: 10.3390/cancers16010220.

Application of the Milan System for Reporting Salivary Gland Cytology: A Prospective Study.

Bhushan R, Priyadarshini Shrivastava J, Verma V Iran J Pathol. 2023; 18(4):439-448.

PMID: 38024544 PMC: 10646740. DOI: 10.30699/IJP.2023.199632.3098.

A Study on Myloblastosis Gene (MYB) in Adenoid Cystic Carcinoma Using the New IHC Marker MYB (SZ04-81).

T R P, M S, Kripesh G Indian J Otolaryngol Head Neck Surg. 2023; 75(3):1414-1420.

PMID: 37636647 PMC: 10447822. DOI: 10.1007/s12070-023-03471-4.

References

Williams N, Boyd D, Choy L, Hanchard B . Salivary gland lesions: a Jamaican perspective. West Indian Med J. 2001; 50(1):62-5. View

de Oliveira F, Duarte E, Taveira C, Maximo A, de Aquino E, Alencar R . Salivary gland tumor: a review of 599 cases in a Brazilian population. Head Neck Pathol. 2010; 3(4):271-5. PMC: 2811571. DOI: 10.1007/s12105-009-0139-9. View

Bello I, Salo T, Dayan D, Tervahauta E, Almangoush A, Schnaiderman-Shapiro A . Epithelial salivary gland tumors in two distant geographical locations, Finland (Helsinki and Oulu) and Israel (Tel Aviv): a 10-year retrospective comparative study of 2,218 cases. Head Neck Pathol. 2012; 6(2):224-31. PMC: 3370031. DOI: 10.1007/s12105-011-0316-5. View

Brandwein M, Ivanov K, Wallace D, Hille J, Wang B, Fahmy A . Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001; 25(7):835-45. DOI: 10.1097/00000478-200107000-00001. View

Dong C, Hemminki K . Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Br J Cancer. 2001; 85(7):997-1005. PMC: 2375099. DOI: 10.1054/bjoc.2001.1998. View

Rinaldo A, Shaha A, Pellitteri P, Bradley P, Ferlito A . Management of malignant sublingual salivary gland tumors. Oral Oncol. 2003; 40(1):2-5. DOI: 10.1016/s1368-8375(03)00104-0. View

SPIRO R, Huvos A, Berk R, Strong E . Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am J Surg. 1978; 136(4):461-8. DOI: 10.1016/0002-9610(78)90262-3. View

Nascimento A, Amaral L, Prado L, KLIGERMAN J, Silveira T . Mucoepidermoid carcinoma of salivary glands: a clinicopathologic study of 46 cases. Head Neck Surg. 1986; 8(6):409-17. DOI: 10.1002/hed.2890080604. View

Chidzonga M, Lopez Perez V . Salivary gland tumours in Zimbabwe: report of 282 cases. Int J Oral Maxillofac Surg. 1995; 24(4):293-7. DOI: 10.1016/s0901-5027(95)80032-8. View

10.

Nagler R, Laufer D . Tumors of the major and minor salivary glands: review of 25 years of experience. Anticancer Res. 1997; 17(1B):701-7. View

11.

Sur R, Donde B, Levin V, Pacella J, Kotzen J, Cooper K . Adenoid cystic carcinoma of the salivary glands: a review of 10 years. Laryngoscope. 1997; 107(9):1276-80. DOI: 10.1097/00005537-199709000-00022. View

12.

Ostman J, ANNEROTH G, Gustafsson H, Tavelin B . Malignant salivary gland tumours in Sweden 1960-1989--an epidemiological study. Oral Oncol. 1997; 33(3):169-76. DOI: 10.1016/s0964-1955(96)00077-2. View

13.

Rice D . Malignant salivary gland neoplasms. Otolaryngol Clin North Am. 1999; 32(5):875-86. DOI: 10.1016/s0030-6665(05)70179-1. View

14.

Kokemueller H, Brueggemann N, Swennen G, Eckardt A . Mucoepidermoid carcinoma of the salivary glands--clinical review of 42 cases. Oral Oncol. 2004; 41(1):3-10. DOI: 10.1016/j.oraloncology.2004.01.017. View

15.

Bell R, Dierks E, Homer L, Potter B . Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg. 2005; 63(7):917-28. DOI: 10.1016/j.joms.2005.03.006. View

16.

Ito F, Ito K, Vargas P, de Almeida O, Lopes M . Salivary gland tumors in a Brazilian population: a retrospective study of 496 cases. Int J Oral Maxillofac Surg. 2005; 34(5):533-6. DOI: 10.1016/j.ijom.2005.02.005. View

17.

Ruiz-Godoy L, Suarez L, Mosqueda A, Meneses A . Polymorphous low-grade adenocarcinoma of the parotid gland. Case report and review of the literature. Med Oral Patol Oral Cir Bucal. 2007; 12(1):E30-3. View

18.

Jaafari-Ashkavandi Z, Ashraf M, Moshaverinia M . Salivary gland tumors: a clinicopathologic study of 366 cases in southern Iran. Asian Pac J Cancer Prev. 2013; 14(1):27-30. DOI: 10.7314/apjcp.2013.14.1.27. View

19.

Otoh E, Johnson N, Olasoji H, Danfillo I, Adeleke O . Salivary gland neoplasms in Maiduguri, north-eastern Nigeria. Oral Dis. 2005; 11(6):386-91. DOI: 10.1111/j.1601-0825.2005.01137.x. View

20.

Rapidis A, Givalos N, Gakiopoulou H, Stavrianos S, Faratzis G, Lagogiannis G . Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients. Oral Oncol. 2006; 43(2):130-6. DOI: 10.1016/j.oraloncology.2006.03.001. View